HUTCHMED's New aDrug Application for Tazemetostat in Relapsed or Refractory Follicular Lymphoma Granted Priority Review by China NMPA

HUTCHMED (China) Limited (“HUTCHMED”)  announces that the New Drug Application (“NDA”) for tazemetostat for the treatment of...

July 04, 2024 | Thursday | News
CSL Behring Achieves European Milestone with First Real-World Treatments of Hemophilia B Using HEMGENIX® Gene Therapy

Global biotechnology leader CSL Behring  announced that two hemophilia B patients were treated with the gene therapy HEMGENIX® (etranacogene dez...

July 04, 2024 | Thursday | News
Vertex Pharmaceuticals' Vanza Triple Granted Priority Review by FDA with Target Action Date of January 2, 2025

Vanza triple granted priority review with Prescription Drug User Fee Act (PDUFA) target action date of January 2, 2025 – - EU Marketing Authorizat...

July 03, 2024 | Wednesday | News
FDA Approves Eli Lilly's Kisunla™ for Early Symptomatic Alzheimer's Disease

Kisunla slowed cognitive and functional decline by up to 35% compared to placebo at 18 months in its pivotal Phase 3 study and reduced participants' risk...

July 03, 2024 | Wednesday | News
Samsung Bioepis Receives FDA Approval for PYZCHIVA® as Biosimilar to Stelara for Multiple Inflammatory Conditions

Samsung Bioepis Co., Ltd. announced that the U.S. Food and Drug Administration (FDA) has approved the Biologics License Application (BLA) for PYZCHIVA&re...

July 01, 2024 | Monday | News
SCG Cell Therapy Receives FDA Approval for IND to Initiate HPV TCR T Cell Therapy Trials in Singapore

SCG Cell Therapy Pte Ltd (SCG), a biotechnology company developing novel immunotherapies for infectious diseases and their associated cancers, today anno...

July 01, 2024 | Monday | News
Cepheid Secures FDA Authorization and CLIA Waiver for Revolutionary Xpert® HCV Test

Cepheid announced today that it has received FDA De Novo marketing authorization and Clinical Laboratory Improvement Amendments (CLIA) Waiver approval for ...

June 28, 2024 | Friday | News
Regulatory Review Begins for Bavarian Nordic's Single-Dose Chikungunya Vaccine in EU and U.S.

Regulatory review of the single-dose CHIKV VLP vaccine candidate for immunization to prevent disease caused by chikungunya virus infection in individua...

June 26, 2024 | Wednesday | News
BioNTech and DualityBio's ADC Candidate BNT324/DB-1311 Gains FDA Fast-Track Status for Prostate Cancer

The status is based on preclinical data and data from an ongoing phase 1/2 study for BNT324/DB-1311; preliminary phase 1/2 clinical data showed anti-tu...

June 25, 2024 | Tuesday | News
Japan Approves Takeda's LIVTENCITY® for Post-Transplant CMV Infection

Takeda announced that LIVTENCITY® (maribavir) has been approved by the Japanese Ministry of Health, Labour and Welfare (MHLW) for post-transplant cy...

June 24, 2024 | Monday | News
AbbVie’s SKYRIZI® Gains FDA Approval for Moderate to Severe Ulcerative Colitis and Crohn's Disease Following Successful Phase 3 Trials

AbbVie announced that the U.S. Food and Drug Administration (FDA) has approved SKYRIZI® (risankizumab-rzaa) for adults with moderately to severely ac...

June 20, 2024 | Thursday | News
Milestone Scientific Receives Regulatory Approval to Launch CompuFlo® Epidural System in Brazil

Milestone Scientific , a leading developer of computerized drug delivery instruments that provide painless and precise injections, announces that it has ...

June 19, 2024 | Wednesday | News
Junshi Biosciences' Toripalimab Approved in China for First-Line Treatment of Extensive-Stage Small Cell Lung Cancer

Shanghai Junshi Biosciences , a leading innovation-driven biopharmaceutical company dedicated to the discovery, development, and commercialization of nov...

June 18, 2024 | Tuesday | News
Danish MedTech Company °MEQU Secures FDA Clearance for Portable Blood and IV Fluid Warmer

Danish MedTech company, °MEQU announces 510(k) regulatory clearance from the U.S. Food and Drug Administration (FDA) of the °M Warmer System - a ...

June 10, 2024 | Monday | News

Survey Box

Poll of the Week

Which area of biopharmaceutical research excites you the most?

× Please select an option to participate in the poll.
Processing...
× You have successfully cast your vote.
 {{ optionDetail.option }}  {{ optionDetail.percentage }}%
 {{ optionDetail.percentage }}% Complete
More polls
Stay Connected

Sign up to our free newsletter and get the latest news sent direct to your inbox

© 2025 Biopharma Boardroom. All Rights Reserved.

Show

Forgot your password?

Show

Show

Lost your password? Please enter your email address. You will receive a link to create a new password.

Back to log-in

Close